Falls and fractures in patients chronically treated with antiepileptic drugs
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 13, 2011
- Accepted December 8, 2011
- First Published June 13, 2012.
Article Versions
- Previous version (June 13, 2012 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Baemisla Shiek Ahmad, MD,
- Keith David Hill, PhD,
- Terence John O'Brien, MD,
- Alexandra Gorelik, MSc,
- Natalie Habib, PhD and
- John Dennis Wark, PhD
- Baemisla Shiek Ahmad, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Dr Baemisla receives support for her PhD from University of Malaya; Ministry of Higher Education (MOHE), Malaysia.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Keith David Hill, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Department of Veterans’ Affairs, 2011-12; NHMRC project grant; , 2011-2014
NONE
Skobie MacKinnon Fund
NONE
NONE
NONE
NONE
NONE
NONE
- Terence John O'Brien, MD,
Janssen-Cilag, Chair, Neurolept advisory board, 2008
NONE
UCB Pharma, speaker honoraria; Sanofi, speaker honoraria; Sigen, speaker honoraria
Epilepsia (2007-9); Journal of Clinical Neuroscience; ; Epilepsy and Behavior;
NONE
NONE
Educational symposia:; Janssen-Cilag 2008&9; Sanofi-Aventis 2009
NONE
NONE
NONE
NONE
UCB; Abbott
NHMRC Project grants (Australia) 2008-11
NONE
RMH Neuroscience Foundation, NARSAD 08, 09; Epilepsy Research Foundation 2009
NONE
NONE
NONE
NONE
NONE
NONE
- Alexandra Gorelik, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Natalie Habib, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- John Dennis Wark, PhD
Amgen/GSK; Novartis; Lactopharma
NONE
(1.) Servier, travel grant for conference and investigator meeting attendance; Servier, speaker honoraria; Amgen, speaker honoraria; Novartis, speaker honoraria; Sanofi-Aventis, speaker honoraria; Eli Lilly, speaker honoraria; Merck, Sharp and Dohme, speaker honoraria
Clinical Science, specialist editor, 1999 - 2008 2. Osteoporosis International, editorial board member, 2005 - current; Journal of Osteoporosis, editorial board member, 2008 - current
NONE
Physical Activity and Bone Health, Human Kinetics Publishers, Champaign, 2001
NONE
Vactec; AstraZeneca Speakers’ Bureaus:; Servier; Amgen; Novartis; Sanofi-Aventis; Eli Lilly; Merck, Sharp and Dohme
NONE
NONE
Royal Melbourne Hospital Bone Densitometry Unit, bone densitry testing, 10%, 1988 - present
Novartis; UCB Pharma; Sanofi-Aventis; Eli Lilly
National Health and Medical Research Council of Australia, multiple grants, chief investigator, 2009 - present; Victorian Cancer Agency, chief investigator, 2010 - present; ANZ Trustees, investigator, 2009 - 2010
Monash University; LaTrobe University
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Medicine (B.S.A., T.J.O., N.H., J.D.W.), Department of Neurology (T.J.O.), and Melbourne EpiCentre (A.G.), Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria; Musculoskeletal Research Centre and School of Physiotherapy (K.D.H.), La Trobe University and Northern Health, Bundoora, Victoria; National Ageing Research Institute (K.D.H.), Parkville, Victoria; The Royal Melbourne Hospital Bone and Mineral Service (J.D.W.), Parkville, Victoria; School of Physiotherapy (K.D.H.), Curtin University, Perth, Western Australia, Australia; and Department of Physiology (B.S.A.), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- Correspondence & reprint requests to Dr. Wark: jdwark{at}unimelb.edu.au
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Effect of antiepileptic medication on bone mineral measuresS. J. Petty, L. M. Paton, T. J. O'Brien et al.Neurology, November 07, 2005 -
Articles
Use of antiepileptic drugs and risk of fracturesCase–control study among patients with epilepsyP. C. Souverein, D. J. Webb, J. G. Weil et al.Neurology, May 08, 2006 -
Editorials
Falls and fractures in patients with epilepsyIs there an increased risk? If so, why?Alison M. Pack et al.Neurology, June 13, 2012 -
Articles
Menopause and bone density issues for women with epilepsyCynthia L. Harden et al.Neurology, September 22, 2003